Better and more affordable medicine through porous silica
As a world leader in the development of nanoporous silica particles for drug development and chromatography separation, Nanologica aims to make a positive impact to the world by leveraging its expertise for the betterment of mankind.
Nanologica in brief
Better and more affordable medicine through porous silica
As a world leader in the development of nanoporous silica particles for drug development and chromatography separation, Nanologica aims to make a positive impact to the world by leveraging its expertise for the betterment of mankind.
Nanologica in brief
Better and more affordable medicine through porous silica
As a world leader in the development of nanoporous silica particles for drug development and chromatography separation, Nanologica aims to make a positive impact to the world by leveraging its expertise for the betterment of mankind.
Nanologica in brief

Latest News & PR

Nanologica Recruits VP Chromatography

6 December, 2021

Nanologica has recruited Katarina Alenäs as VP Chromatography to lead Nanologica’s sales organization within Chromatography globally. As sales start for preparative chromatography approaches, Nanologica’s sales organization is now strengthened with Katarina Alenäs as VP Chromatography. The assignment includes leading the sales organization and driving the work globally. Nanologica thus has its own sales organization covering

Read more »

Nanologica rekryterar VP Chromatography

6 December, 2021

Nanologica har rekryterat Katarina Alenäs som VP Chromatography för att leda Nanologicas säljorganisation inom kromatografi globalt. I och med att försäljningsstart inom preparativ kromatografi närmar sig stärks nu Nanologicas försäljningsorganisation med Katarina Alenäs som VP Chromatography. Uppdraget innebär att leda försäljningsorganisationen och driva arbetet globalt. Nanologica får därmed en egen säljorganisation som täcker samtliga stora

Read more »
All news

Investor relationships

Nanologica is a public company listed for trade on Spotlight Stock Market. For information regarding financial reports, press releases, presentations and share holder information, please visit our investor relations section.

Investor Relations

Presentation of Nanologica

Company presentation made by CEO Andreas Bhagwani on May 28, 2019.
For more videos about the Company as well as video presentations of interim reports, please refer to Investor Relations.